Solve Therapeutics
Clinical trials sponsored by Solve Therapeutics, explained in plain language.
-
New drug SLV-154 enters human trials for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug called SLV-154 in about 70 adults with advanced solid tumors that have spread. The main goal is to find the safest dose and check for side effects. Participants have cancers like head and neck, lung, breast, or ovarian cancer that haven't r…
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated May 26, 2026 06:16 UTC
-
New drug SLV-324 enters human testing for advanced cancers
Disease control Recruiting nowThis early-stage study tests a new drug, SLV-324, in about 70 adults whose solid tumors have spread and stopped responding to standard treatments. The main goal is to find a safe dose and see how the body handles the drug. Researchers will also watch for any signs that the drug i…
Phase: PHASE1 • Sponsor: Solve Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:04 UTC